The promise of structural genomics in the discovery of new antimicrobial agents

被引:11
作者
Buchanan, SG [1 ]
Sauder, JM [1 ]
Harris, T [1 ]
机构
[1] Struct GenomiX, Bioinformat, San Diego, CA 92121 USA
关键词
D O I
10.2174/1381612023394809
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Structural Genomics stands out among the emerging fields of proteomics since it influences the drug discovery process at so many points. Recent developments in protein expression technologies, x-ray crystallography and NMR spectroscopy provide the essential elements for high-throughput structure determination platforms. Bioinformatics methods to interrogate the resulting data will provide comprehensive, genome-wide databases of protein structure. Genomic sequencing and methods for high-throughput expression and protein purification are furthest advanced for microbial genes and so these have been the early targets for structural genomics initiatives. The information will be invaluable in understanding gene function, designing broad-spectrum small molecule inhibitors and in better understanding drug-host interactions.
引用
收藏
页码:1173 / 1188
页数:16
相关论文
共 120 条
[101]   Evolution of function in protein superfamilies, from a structural perspective [J].
Todd, AE ;
Orengo, CA ;
Thornton, JM .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (04) :1113-1143
[102]   The sequence of the human genome [J].
Venter, JC ;
Adams, MD ;
Myers, EW ;
Li, PW ;
Mural, RJ ;
Sutton, GG ;
Smith, HO ;
Yandell, M ;
Evans, CA ;
Holt, RA ;
Gocayne, JD ;
Amanatides, P ;
Ballew, RM ;
Huson, DH ;
Wortman, JR ;
Zhang, Q ;
Kodira, CD ;
Zheng, XQH ;
Chen, L ;
Skupski, M ;
Subramanian, G ;
Thomas, PD ;
Zhang, JH ;
Miklos, GLG ;
Nelson, C ;
Broder, S ;
Clark, AG ;
Nadeau, C ;
McKusick, VA ;
Zinder, N ;
Levine, AJ ;
Roberts, RJ ;
Simon, M ;
Slayman, C ;
Hunkapiller, M ;
Bolanos, R ;
Delcher, A ;
Dew, I ;
Fasulo, D ;
Flanigan, M ;
Florea, L ;
Halpern, A ;
Hannenhalli, S ;
Kravitz, S ;
Levy, S ;
Mobarry, C ;
Reinert, K ;
Remington, K ;
Abu-Threideh, J ;
Beasley, E .
SCIENCE, 2001, 291 (5507) :1304-+
[103]   STRUCTURE-BASED DRUG DESIGN - PROGRESS, RESULTS AND CHALLENGES [J].
VERLINDE, CLMJ ;
HOL, WGJ .
STRUCTURE, 1994, 2 (07) :577-587
[104]   Rapid protein-folding assay using green fluorescent protein [J].
Waldo, GS ;
Standish, BM ;
Berendzen, J ;
Terwilliger, TC .
NATURE BIOTECHNOLOGY, 1999, 17 (07) :691-695
[105]   E-coli hemolysin E (HlyE, ClyA, SheA):: X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy [J].
Wallace, AJ ;
Stillman, TJ ;
Atkins, A ;
Jamieson, SJ ;
Bullough, PA ;
Green, J ;
Artymiuk, PJ .
CELL, 2000, 100 (02) :265-276
[106]   Two's company, three's a crowd: The yeast two hybrid system for mapping molecular interactions [J].
Warbrick, E .
STRUCTURE, 1997, 5 (01) :13-17
[107]  
Wong KK, 1998, ADV EXP MED BIOL, V456, P197
[108]  
Würtele M, 2001, NAT STRUCT BIOL, V8, P23
[109]   Antibacterial and anti-inflammatory agents that target endotoxin [J].
Wyckoff, TJO ;
Raetz, CRH ;
Jackman, JE .
TRENDS IN MICROBIOLOGY, 1998, 6 (04) :154-159
[110]   Humanized xenobiotic response in mice expressing nuclear receptor SXR [J].
Xie, W ;
Barwick, JL ;
Downes, M ;
Blumberg, B ;
Simon, CM ;
Nelson, MC ;
Neuschwander-Tetri, BA ;
Bruntk, EM ;
Guzelian, PS ;
Evans, RM .
NATURE, 2000, 406 (6794) :435-439